Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder

NCT00088036 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Borderline Personality Disorder

Interventions

DRUG: Olanzapine

Sponsor

Eli Lilly and Company